Anti-VEGFB Antibody (9L289)
Référence NB-64-163996-25uL
Conditionnement : 25uL
Marque : Neo Biotech
Remove All
Anti-VEGFB Antibody (9L289)
Copy Product InfoSynonyms:
Catalog No. TMAB-14079 Copy Product Info
Anti-VEGFB Antibody (9L289) is a Rabbit antibody targeting VEGFB. Anti-VEGFB Antibody (9L289) can be used in WB.
For research use only—not for human use. No sales to individuals. Use as intended only.
Product Information
Bioactivity
Antigen Details
Chemical Properties
Stability & Storage
| Description | Anti-VEGFB Antibody (9L289) is a Rabbit antibody targeting VEGFB. Anti-VEGFB Antibody (9L289) can be used in WB. |
| Ig Type | IgG |
| Clone | 9L289 |
| Reactivity | Human,Mouse |
| Verified Activity | Western blot analysis of 293T cell transfected with VEGFB recombinant protein. Using VEGFB (TMAB-14079) monoclonal antibody at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r. T. for 60 min. |
| Application | WB |
| Recommended Dose | WB: 1:1000-2000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Subcellular Localization | Secreted. Secreted but remains associated to cells or to the extracellular matrix unless released by heparin. |
| Tissue Specificity | Expressed in all tissues except liver. Highest levels found in heart, skeletal muscle and pancreas. |
| Construction | Recombinant Antibody |
| Purification | Protein A purified |
| Appearance | Liquid |
| Formulation | 10mM phosphate buffered saline (pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. |
| Research Background | Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis. |
| Immunogen | A synthesized peptide: human VEGF B |
| Antigen Species | Human |
| Gene Name | VEGFB |
| Gene ID | 7423 |
| Protein Name | Vascular endothelial growth factor B |
| Uniprot ID | P49765 |
| Function | The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described and include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factors (VEGFs). The VEGF protein family is comprised of VEGF, VEGF-B, VEGF-C and VEGF-D, all of which may exhibit angiogenic function in vivo. VEGF-B, which exists as two alternatively spliced isoforms known as VEGF-B167 and VEGF-B186, is abundantly expressed in heart and skeletal muscle and is frequently co-expressed with VEGF. VEGF-C binds to and specifically activates Flt-4 and Flk-1. |
| Molecular Weight | Theoretical: 22 kDa. Actual: 19 kDa. |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
Related Tags: Anti-VEGFB Antibody (9L289) molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote

